Theranostics in Cancer Management
Integrating Diagnostics and Therapeutic Strategies
- 1st Edition - October 8, 2025
- Latest edition
- Editors: Kuttiappan Anitha, Shvetank Bhatt, Santenna Chenchula
- Language: English
Theranostics in Cancer Management: Integrating Diagnostics and Therapeutic Strategies introduces a transformative paradigm in clinical oncology, heralding a new era of precis… Read more
World Book Day celebration
Where learning shapes lives
Up to 25% off trusted resources that support research, study, and discovery.
Description
Description
Comprising 15 chapters, it offers an invaluable resource for health professionals, scientists, researchers, practitioners, and students who seek to expand their understanding in this evolving field. The emphasis on practical applications and emerging technologies makes it a timely addition to the field of oncology.
Key features
Key features
- Unfolds the current challenges and opportunities in theranostics encompasses an exploration of regulatory landscapes, economic implications, and strategies to enhance cancer management
- Bridges the gap between research and clinical practice, offering guidance to clinicians and researchers, contributing to evidence-based practice, and inspiring future research in the dynamic field of theranostics in oncology
- Provides a valuable guide for professionals navigating the complex and transformative journey of integrated diagnostics and therapeutic strategies in cancer management
Readership
Readership
Table of contents
Table of contents
2. Theranostics in Breast Cancer
3. Theranostics in Gastric and Colorectal cancer
4. Theranostics in Cervical Cancer
5. Theranostics in Lung Cancer
6. Theranostics in Hepatocellular Carcinoma
7. Theranostics in Brain cancer
8. Theranostics in Pancreatic Cancer
9. Theranostics in Prostate Cancer
10. Theranostics in Ovarian Cancer
11. Theranostics in Bone Cancer
12. Theranostics in Skin cancer
13. Challenges and Limitations of Theranostics in Precision Oncology
14. Recent evidence of Theranostics and its Perspectives on Clinical Advances and Emerging Approaches
15. Theranostics and Artificial Intelligence as Tools to Detect various cancer
Product details
Product details
- Edition: 1
- Latest edition
- Published: October 21, 2025
- Language: English
About the editors
About the editors
KA
Kuttiappan Anitha
Dr. Kuttiappan Anitha is working as Assistant Professor in School of Pharmacy and Technology Management (SPTM), SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-University, Shirpur. She has broad teaching and research experience. Dr. Anitha is recipient of “Excellence in Academic Award” 2022 from International School of Technology and Sciences Affiliated from Govt. of India. She has guided more than 45 M.Pharm students and more than 10 batches of UG Projects. She has more than 30 publications in both national and international journals. Her area of expertise includes Immunooncology, endocrine areas, Gut Microbiota, infectious Diseases. She has also written several books and many book chapters. She has organized Conferences/seminars at university levels.
SB
Shvetank Bhatt
Dr. Shvetank Bhatt is an accomplished Associate Professor in the School of Health Sciences and Technology at Dr. Vishwanath Karad MIT World Peace University, located in Pune, Maharashtra, India. He holds an M. Pharm degree in Pharmacology from Manipal College of Pharmaceutical Sciences, MAHE, Manipal, Karnataka, and a Ph.D. in Neuropharmacology from Birla Institute of Technology & Science (BITS) Pilani, Pilani Campus, Rajasthan. With many years of industrial and academic research experience, Dr. Bhatt specializes in CNS disorders, pain, inflammation, and immuno-oncology. He has received numerous accolades, including the Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award for Best Paper in Pharmacology-IJPER in 2012 and 2014. Dr. Bhatt has published dozens of papers in various national and international journals. Dr. Bhatt is a life member of the Association of Pharmaceutical Teachers of India (APTI) and the Indian Pharmacological Society (IPS).
SC
Santenna Chenchula
Dr. Santenna Chenchula has been an academic faculty member and researcher in the Department of Pharmacology at the All India Institute of Medical Sciences (AIIMS) Bhopal. His research interests span across clinical pharmacology, with a focus on molecular medicine, precision medicine, pharmacogenomics, oncology, rational drug use, antimicrobial resistance, vaccines, drug discovery, clinical trials, and pharmacovigilance. He serves as a reviewer for several national and international journals in the field of biomedical research. To date, he has published dozens of articles in international and national journals and has authored several books as the corresponding first author. He is an active member of the Pharmacogenomics Research Network (PGRN), The American Society for Clinical Pharmacology and Therapeutics (ASCPT), and the Global Center for Evidence Synthesis (GCES). Currently, he is pursuing a PhD in clinical pharmacology, specializing in Precision Medicine and Pharmacogenomics.